Literature DB >> 12381397

Heterologous production of bacteriocins by lactic acid bacteria.

J M Rodríguez1, M I Martínez, N Horn, H M Dodd.   

Abstract

Over the last two decades, bacteriocins produced by lactic acid bacteria (LAB) have been the subject of considerable research and industrial interest due to their potential as food biopreservatives. The development of heterologous expression systems for such antimicrobial compounds may offer a number of advantages over native systems, such as facilitating the control of bacteriocin gene expression or achieving higher production levels. In addition, the heterologous production by food-grade LAB offers an attractive method for overcoming some of the adverse situations that may affect the effectiveness of some bacteriocins in food systems. Construction of multibacteriocinogenic strains or acquisition of antimicrobial properties by industrial strains are further objectives that can be achieved through the use of heterologous gene expression systems. The development of new biotechnological tools and recent advances in LAB genetics account for the escalating number of studies dealing with heterologous production of bacteriocins by such hosts. This paper reviews the literature published on the subject and compares the different experimental strategies that have been used up to the present for this purpose.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12381397     DOI: 10.1016/s0168-1605(02)00153-8

Source DB:  PubMed          Journal:  Int J Food Microbiol        ISSN: 0168-1605            Impact factor:   5.277


  25 in total

1.  A Simple Method for the Efficient Isolation of Genomic DNA from Lactobacilli Isolated from Traditional Indian Fermented Milk (dahi).

Authors:  Sachinandan De; Gurpreet Kaur; Amit Roy; Gaurav Dogra; Ramakant Kaushik; Paras Yadav; Rameshwar Singh; Tirtha Kumar Datta; Surender Lal Goswami
Journal:  Indian J Microbiol       Date:  2011-01-30       Impact factor: 2.461

2.  Transformation of, and heterologous protein expression in, Lactobacillus agilis and Lactobacillus vaginalis isolates from the chicken gastrointestinal tract.

Authors:  David P Stephenson; Robert J Moore; Gwen E Allison
Journal:  Appl Environ Microbiol       Date:  2010-11-12       Impact factor: 4.792

3.  Development of a homologous expression system for and systematic site-directed mutagenesis analysis of thurincin H, a bacteriocin produced by Bacillus thuringiensis SF361.

Authors:  Gaoyan Wang; David C Manns; John J Churey; Randy W Worobo
Journal:  Appl Environ Microbiol       Date:  2014-06       Impact factor: 4.792

4.  Sec-mediated secretion of bacteriocin enterocin P by Lactococcus lactis.

Authors:  Carmen Herranz; Arnold J M Driessen
Journal:  Appl Environ Microbiol       Date:  2005-04       Impact factor: 4.792

5.  Secretion of recombinant pediocin PA-1 by Bifidobacterium longum, using the signal sequence for bifidobacterial alpha-amylase.

Authors:  Gi-Seong Moon; Yu-Ryang Pyun; Myeong Soo Park; Geun Eog Ji; Wang June Kim
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

Review 6.  The continuing story of class IIa bacteriocins.

Authors:  Djamel Drider; Gunnar Fimland; Yann Héchard; Lynn M McMullen; Hervé Prévost
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

Review 7.  Bacteriocin diversity in Streptococcus and Enterococcus.

Authors:  Ingolf F Nes; Dzung B Diep; Helge Holo
Journal:  J Bacteriol       Date:  2006-11-10       Impact factor: 3.490

8.  Probiotics prophylaxis in pyelonephritis infants with normal urinary tracts.

Authors:  Seung Joo Lee; Jihae Cha; Jung Won Lee
Journal:  World J Pediatr       Date:  2016-04-08       Impact factor: 2.764

Review 9.  Genome Editing of Food-Grade Lactobacilli To Develop Therapeutic Probiotics.

Authors:  Jan-Peter van Pijkeren; Rodolphe Barrangou
Journal:  Microbiol Spectr       Date:  2017-09

10.  Probiotics prophylaxis in infants with primary vesicoureteral reflux.

Authors:  Seung Joo Lee; Jung Won Lee
Journal:  Pediatr Nephrol       Date:  2014-10-30       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.